BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 28807161)

  • 1. Phytochemical Modulation of Apoptosis and Autophagy: Strategies to Overcome Chemoresistance in Leukemic Stem Cells in the Bone Marrow Microenvironment.
    Owen HC; Appiah S; Hasan N; Ghali L; Elayat G; Bell C
    Int Rev Neurobiol; 2017; 135():249-278. PubMed ID: 28807161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches.
    Hira VVV; Van Noorden CJF; Carraway HE; Maciejewski JP; Molenaar RJ
    Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):183-198. PubMed ID: 28363872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting AMPK-ULK1-mediated autophagy for combating BET inhibitor resistance in acute myeloid leukemia stem cells.
    Jang JE; Eom JI; Jeung HK; Cheong JW; Lee JY; Kim JS; Min YH
    Autophagy; 2017 Apr; 13(4):761-762. PubMed ID: 28118076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: From biology to therapeutic targeting.
    Chiarini F; Lonetti A; Evangelisti C; Buontempo F; Orsini E; Evangelisti C; Cappellini A; Neri LM; McCubrey JA; Martelli AM
    Biochim Biophys Acta; 2016 Mar; 1863(3):449-463. PubMed ID: 26334291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPK-ULK1-Mediated Autophagy Confers Resistance to BET Inhibitor JQ1 in Acute Myeloid Leukemia Stem Cells.
    Jang JE; Eom JI; Jeung HK; Cheong JW; Lee JY; Kim JS; Min YH
    Clin Cancer Res; 2017 Jun; 23(11):2781-2794. PubMed ID: 27864418
    [No Abstract]   [Full Text] [Related]  

  • 6. CD25 targeted therapy of chemotherapy resistant leukemic stem cells using DR5 specific TRAIL peptide.
    Madhumathi J; Sridevi S; Verma RS
    Stem Cell Res; 2017 Mar; 19():65-75. PubMed ID: 28076753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. beta-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia.
    Hu Y; Chen Y; Douglas L; Li S
    Leukemia; 2009 Jan; 23(1):109-16. PubMed ID: 18818703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemia Stem Cells Microenvironment.
    Tabe Y; Konopleva M
    Adv Exp Med Biol; 2017; 1041():19-32. PubMed ID: 29204827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Microenvironment in Resistance to Therapy in AML.
    Tabe Y; Konopleva M
    Curr Hematol Malig Rep; 2015 Jun; 10(2):96-103. PubMed ID: 25921386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment.
    Arrigoni E; Del Re M; Galimberti S; Restante G; Rofi E; Crucitta S; Baratè C; Petrini M; Danesi R; Di Paolo A
    Stem Cells Transl Med; 2018 Mar; 7(3):305-314. PubMed ID: 29418079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
    Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
    Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
    Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
    Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow microenvironment: The guardian of leukemia stem cells.
    Houshmand M; Blanco TM; Circosta P; Yazdi N; Kazemi A; Saglio G; Zarif MN
    World J Stem Cells; 2019 Aug; 11(8):476-490. PubMed ID: 31523368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the Wnt Signaling Pathway in Acute Myeloid Leukemia Stem Cells: A Feasible Key against Relapses.
    Láinez-González D; Alonso-Aguado AB; Alonso-Dominguez JM
    Biology (Basel); 2023 May; 12(5):. PubMed ID: 37237497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy is dispensable for Kmt2a/Mll-Mllt3/Af9 AML maintenance and anti-leukemic effect of chloroquine.
    Chen X; Clark J; Wunderlich M; Fan C; Davis A; Chen S; Guan JL; Mulloy JC; Kumar A; Zheng Y
    Autophagy; 2017 May; 13(5):955-966. PubMed ID: 28282266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells.
    Mohammadi S; Ghaffari SH; Shaiegan M; Zarif MN; Nikbakht M; Akbari Birgani S; Alimoghadam K; Ghavamzadeh A
    Life Sci; 2016 May; 152():190-8. PubMed ID: 27063991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt Signaling in Leukemia and Its Bone Marrow Microenvironment.
    Ruan Y; Kim HN; Ogana H; Kim YM
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthelmintic Niclosamide Disrupts the Interplay of p65 and FOXM1/β-catenin and Eradicates Leukemia Stem Cells in Chronic Myelogenous Leukemia.
    Jin B; Wang C; Li J; Du X; Ding K; Pan J
    Clin Cancer Res; 2017 Feb; 23(3):789-803. PubMed ID: 27492973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Cadherin Aided in Maintaining the Characteristics of Leukemic Stem Cells.
    Zhi L; Gao Y; Yu C; Zhang Y; Zhang B; Yang J; Yao Z
    Anat Rec (Hoboken); 2016 Jul; 299(7):990-8. PubMed ID: 27064800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference?
    Martiáñez Canales T; de Leeuw DC; Vermue E; Ossenkoppele GJ; Smit L
    Cancers (Basel); 2017 Jun; 9(7):. PubMed ID: 28665351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.